{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Piper", "alkaloid", "anticancer", "cytotoxic", "drug", "medicinal plants", "metabolites", "natural products", "phenylpropanoid", "piperlongumine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37765054", "DateRevised": {"Year": "2023", "Month": "10", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "09", "Day": "04"}], "Language": ["eng"], "ELocationID": ["1246", "10.3390/ph16091246"], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "16", "Issue": "9", "PubDate": {"Year": "2023", "Month": "Sep", "Day": "04"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "The Antitumor Activity of Piplartine: A Review.", "Abstract": {"AbstractText": ["Cancer is a worldwide health problem with high mortality in children and adults, making searching for novel bioactive compounds with potential use in cancer treatment essential. Piplartine, also known as piperlongumine, is an alkamide isolated from <i>Piper longum</i> Linn, with relevant therapeutic potential. Therefore, this review covered research on the antitumor activity of piplartine, and the studies reported herein confirm the antitumor properties of piplartine and highlight its possible application as an anticancer agent against various types of tumors. The evidence found serves as a reference for advancing mechanistic research on this metabolite and preparing synthetic derivatives or analogs with better antitumor activity in order to develop new drug candidates."]}, "AuthorList": [{"Identifier": ["0000-0001-6192-3691"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departament of Pharmaceutical Sciences, Federal University of Para\u00edba, Jo\u00e3o Pessoa 58051-970, PB, Brazil."}], "LastName": "Duarte", "ForeName": "Allana Brunna S", "Initials": "ABS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departament of Pharmaceutical Sciences, Federal University of Para\u00edba, Jo\u00e3o Pessoa 58051-970, PB, Brazil."}], "LastName": "Gomes", "ForeName": "Rebeca C", "Initials": "RC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departament of Pharmaceutical Sciences, Federal University of Para\u00edba, Jo\u00e3o Pessoa 58051-970, PB, Brazil."}], "LastName": "Nunes", "ForeName": "Vit\u00f3ria Regina V", "Initials": "VRV"}, {"Identifier": ["0000-0002-1702-1102"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departament of Pharmaceutical Sciences, Federal University of Para\u00edba, Jo\u00e3o Pessoa 58051-970, PB, Brazil."}], "LastName": "Gon\u00e7alves", "ForeName": "Juan Carlos R", "Initials": "JCR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departament of Pharmaceutical Sciences, Federal University of Para\u00edba, Jo\u00e3o Pessoa 58051-970, PB, Brazil."}], "LastName": "Correia", "ForeName": "Camylla A", "Initials": "CA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departament of Pharmaceutical Sciences, Federal University of Para\u00edba, Jo\u00e3o Pessoa 58051-970, PB, Brazil."}], "LastName": "Dos Santos", "ForeName": "Ana Zulmira G", "Initials": "AZG"}, {"Identifier": ["0000-0002-7180-4896"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departament of Pharmaceutical Sciences, Federal University of Para\u00edba, Jo\u00e3o Pessoa 58051-970, PB, Brazil."}], "LastName": "de Sousa", "ForeName": "Dami\u00e3o P", "Initials": "DP"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Torre L.A., Siegel R.L., Ward E.M., Jemal A. Global Cancer Incidence and Mortality Rates and Trends\u2013An Update. Cancer Epidemiol. Biomark. Prev. 2016;25:16\u201327. doi: 10.1158/1055-9965.EPI-15-0578.", "ArticleIdList": ["10.1158/1055-9965.EPI-15-0578", "26667886"]}, {"Citation": "Girisa S., Henamayee S., Parama D., Rana V., Dutta U., Kunnumakkara A.B. Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer. Mol. Biomed. 2021;2:21. doi: 10.1186/s43556-021-00035-2.", "ArticleIdList": ["10.1186/s43556-021-00035-2", "PMC8607382", "35006466"]}, {"Citation": "Ahmed S.A., Parama D., Daimari E., Girisa S., Banik K., Harsha C., Dutta U., Kunnumakkara A.B. Rationalizing the therapeutic potential of apigenin against cancer. Life Sci. 2021;267:118814. doi: 10.1016/j.lfs.2020.118814.", "ArticleIdList": ["10.1016/j.lfs.2020.118814", "33333052"]}, {"Citation": "Didkowska J., Wojciechowska U., Michalek I.M., Dos Santos F.L.C. Cancer incidence and mortality in Poland in 2019. Sci. Rep. 2022;12:10875. doi: 10.1038/s41598-022-14779-6.", "ArticleIdList": ["10.1038/s41598-022-14779-6", "PMC9237124", "35760845"]}, {"Citation": "Sung H., Siegel R.L., Jemal A., Ferlay J., Laversanne M., Soerjomataram I., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Zeien J., Qiu W., Triay M., Dhaibar H.A., Cruz-Topete D., Cornett E.M., Urits I., Viswanath O., Kaye A.D. Clinical implications of chemotherapeutic agent organ toxicity on perioperative care. Biomed. Pharmacother. 2022;146:112503. doi: 10.1016/j.biopha.2021.112503.", "ArticleIdList": ["10.1016/j.biopha.2021.112503", "34922113"]}, {"Citation": "Zaimy M.A., Saffarzadeh N., Mohammadi A., Pourghadamyari H., Izadi P., Sarli A., Moghaddam L.K., Paschepari S.R., Azizi H., Torkamandi S., et al. New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles. Cancer Gene Ther. 2017;24:233\u2013243. doi: 10.1038/cgt.2017.16.", "ArticleIdList": ["10.1038/cgt.2017.16", "28574057"]}, {"Citation": "Machado T.Q., da Fonseca A.C.C., Duarte A.B.S., Robbs B.K., de Sousa D.P. A Narrative Review of the Antitumor Activity of Monoterpenes from Essential Oils: An Update. Biomed. Res. Int. 2022;2022:6317201. doi: 10.1155/2022/6317201.", "ArticleIdList": ["10.1155/2022/6317201", "PMC9155973", "35655488"]}, {"Citation": "Thomford N.E., Senthebane D.A., Rowe A., Munro D., Seele P., Maroyi A., Dzobo K. Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery. Int. J. Mol. Sci. 2018;19:1578. doi: 10.3390/ijms19061578.", "ArticleIdList": ["10.3390/ijms19061578", "PMC6032166", "29799486"]}, {"Citation": "Naeem A., Hu P., Yang M., Zhang J., Liu Y., Zhu W., Zheng Q. Natural Products as Anticancer Agents: Current Status and Future Perspectives. Molecules. 2022;27:8367. doi: 10.3390/molecules27238367.", "ArticleIdList": ["10.3390/molecules27238367", "PMC9737905", "36500466"]}, {"Citation": "Ali Abdalla Y.O., Subramaniam B., Nyamathulla S., Shamsuddin N., Arshad N.M., Mun K.S., Awang K., Nagoor N.H. Natural Products for Cancer Therapy: A Review of Their Mechanism of Actions and Toxicity in the Past Decade. J. Trop. Med. 2022;2022:5794350. doi: 10.1155/2022/5794350.", "ArticleIdList": ["10.1155/2022/5794350", "PMC8933079", "35309872"]}, {"Citation": "Atanasov A.G., Zotchev S.B., Dirsch V.M., International Natural Product Sciences Taskforce. Supuran C.T. Natural products in drug discovery: Advances and opportunities. Nat. Rev. Drug Discov. 2021;20:200\u2013216. doi: 10.1038/s41573-020-00114-z.", "ArticleIdList": ["10.1038/s41573-020-00114-z", "PMC7841765", "33510482"]}, {"Citation": "Wang Y., Zhong J., Bai J., Tong R., An F., Jiao P., He L., Zeng D., Long E., Yan J., et al. The Application of Natural Products in Cancer Therapy by Targeting Apoptosis Pathways. Curr. Drug Metab. 2018;19:739\u2013749. doi: 10.2174/1389200219666180511154722.", "ArticleIdList": ["10.2174/1389200219666180511154722", "29749309"]}, {"Citation": "Huang M., Lu J.J., Ding J. Natural Products in Cancer Therapy: Past, Present and Future. Nat. Prod. Bioprospect. 2021;11:5\u201313. doi: 10.1007/s13659-020-00293-7.", "ArticleIdList": ["10.1007/s13659-020-00293-7", "PMC7933288", "33389713"]}, {"Citation": "Fan X., Song J., Zhao Z., Chen M., Tu J., Lu C., Wu F., Zhang D., Weng Q., Zheng L., et al. Piplartine suppresses proliferation and invasion of hepatocellular carcinoma by LINC01391-modulated Wnt/\u03b2-catenin pathway inactivation through ICAT. Cancer Lett. 2019;460:119\u2013127. doi: 10.1016/j.canlet.2019.06.008.", "ArticleIdList": ["10.1016/j.canlet.2019.06.008", "31207322"]}, {"Citation": "Zou Y., Yan C., Zhang H., Xu J., Zhang D., Huang Z., Zhang Y. Synthesis and evaluation of N-heteroaromatic ring-based analogs of piperlongumine as potent anticancer agents. Eur. J. Med. Chem. 2017;138:313\u2013319. doi: 10.1016/j.ejmech.2017.06.046.", "ArticleIdList": ["10.1016/j.ejmech.2017.06.046", "28686911"]}, {"Citation": "Bullova P., Cougnoux A., Abunimer L., Kopacek J., Pastorekova S., Pacak K. Hypoxia potentiates the cytotoxic effect of piperlongumine in pheochromocytoma models. Oncotarget. 2016;7:40531\u201340545. doi: 10.18632/oncotarget.9643.", "ArticleIdList": ["10.18632/oncotarget.9643", "PMC5130026", "27244895"]}, {"Citation": "Liu J., Zhu X., Yu L., Mao M. Discovery of novel sulphonamide hybrids that inhibit LSD1 against bladder cancer cells. J. Enzym. Inhib. Med. Chem. 2022;37:866\u2013875. doi: 10.1080/14756366.2021.2014830.", "ArticleIdList": ["10.1080/14756366.2021.2014830", "PMC8973347", "35350943"]}, {"Citation": "Barreca M., Ingarra A.M., Raimondi M.V., Span\u00f2 V., Piccionello A.P., De Franco M., Menilli L., Gandin V., Miolo G., Barraja P., et al. New tricyclic systems as photosensitizers towards triple negative breast cancer cells. Arch. Pharm. Res. 2022;45:806\u2013821. doi: 10.1007/s12272-022-01414-1.", "ArticleIdList": ["10.1007/s12272-022-01414-1", "PMC9701179", "36399284"]}, {"Citation": "Al-Ghulikah H.A., El-Sebaey S.A., Bass A.K.A., El-Zoghbi M.S. New Pyrimidine-5-Carbonitriles as COX-2 Inhibitors: Design, Synthesis, Anticancer Screening, Molecular Docking, and In Silico ADME Profile Studies. Molecules. 2022;27:7485. doi: 10.3390/molecules27217485.", "ArticleIdList": ["10.3390/molecules27217485", "PMC9658812", "36364312"]}, {"Citation": "Grillone K., Riillo C., Rocca R., Ascrizzi S., Span\u00f2 V., Scionti F., Poler\u00e0 N., Maruca A., Barreca M., Juli G., et al. The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma. Int. J. Mol. Sci. 2022;23:10222. doi: 10.3390/ijms231810222.", "ArticleIdList": ["10.3390/ijms231810222", "PMC9499408", "36142133"]}, {"Citation": "Meegan M.J., Nathwani S., Twamley B., Zisterer D.M., O\u2019Boyle N.M. Piperlongumine (piplartine) and analogues: Antiproliferative microtubule-destabilising agents. Eur. J. Med. Chem. 2017;125:453\u2013463. doi: 10.1016/j.ejmech.2016.09.048.", "ArticleIdList": ["10.1016/j.ejmech.2016.09.048", "27689728"]}, {"Citation": "Niu M., Xu X., Shen Y., Yao Y., Qiao J., Zhu F., Zeng L., Liu X., Xu K. Piperlongumine is a novel nuclear export inhibitor with potent anticancer activity. Chem. Biol. Interact. 2015;237:66\u201372. doi: 10.1016/j.cbi.2015.05.016.", "ArticleIdList": ["10.1016/j.cbi.2015.05.016", "26026911"]}, {"Citation": "Wang X.Q., Wang Y.C., Guo Y.T., Tang X. Effect of Piperlongumine on Drug Resistance Reversal in Human Retinoblastoma HXO-RB44/VCR and SO-Rb50/CBP Cell Lines. Int. J. Clin. Exp. Pathol. 2015;8:2525\u20132534.", "ArticleIdList": ["PMC4440067", "26045758"]}, {"Citation": "Lewis K.M., Bharadwaj U., Eckols T.K., Kolosov M., Kasembeli M.M., Fridley C., Siller R., Tweardy D.J. Small-Molecule Targeting of Signal Transducer and Activator of Transcription (STAT) 3 to Treat Non-Small Cell Lung Cancer. Lung Cancer. 2015;90:182\u2013190. doi: 10.1016/j.lungcan.2015.09.014.", "ArticleIdList": ["10.1016/j.lungcan.2015.09.014", "PMC4619129", "26410177"]}, {"Citation": "Song B., Zhan H., Bian Q., Gu J. Piperlongumine Inhibits Gastric Cancer Cells via Suppression of the JAK1,2/STAT3 Signaling Pathway. Mol. Med. Rep. 2016;13:4475\u20134480. doi: 10.3892/mmr.2016.5091.", "ArticleIdList": ["10.3892/mmr.2016.5091", "27053336"]}, {"Citation": "Karki K., Hedrick E., Kasiappan R., Jin U.H., Safe S. Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription Factors. Cancer Prev. Res. 2017;10:467\u2013477. doi: 10.1158/1940-6207.CAPR-17-0053.", "ArticleIdList": ["10.1158/1940-6207.CAPR-17-0053", "PMC6357769", "28673967"]}, {"Citation": "Harshbarger W., Gondi S., Ficarro S.B., Hunter J., Udayakumar D., Gurbani D., Singer W.D., Liu Y., Li L., Marto J.A., et al. Structural and Biochemical Analyses Reveal the Mechanism of Glutathione S-Transferase Pi 1 Inhibition by the Anti-Cancer Compound Piperlongumine. J. Biol. Chem. 2017;292:112\u2013120. doi: 10.1074/jbc.M116.750299.", "ArticleIdList": ["10.1074/jbc.M116.750299", "PMC5217671", "27872191"]}, {"Citation": "Niu M., Shen Y., Xu X., Yao Y., Fu C., Yan Z., Wu Q., Cao J., Sang W., Zeng L., et al. Piperlongumine Selectively Suppresses ABC-DLBCL through Inhibition of NF-\u039aB P65 Subunit Nuclear Import. Biochem. Biophys. Res. Commun. 2015;462:326\u2013331. doi: 10.1016/j.bbrc.2015.04.136.", "ArticleIdList": ["10.1016/j.bbrc.2015.04.136", "25979358"]}, {"Citation": "Thongsom S., Suginta W., Lee K.J., Choe H., Talabnin C. Piperlongumine induces G2/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway. Apoptosis. 2017;22:1473\u20131484. doi: 10.1007/s10495-017-1422-y.", "ArticleIdList": ["10.1007/s10495-017-1422-y", "28913568"]}, {"Citation": "Liu D., Qiu X.Y., Wu X., Hu D.X., Li C.Y., Yu S.B., Pan F., Chen X.Q. Piperlongumine Suppresses Bladder Cancer Invasion via Inhibiting Epithelial Mesenchymal Transition and F-Actin Reorganization. Biochem. Biophys. Res. Commun. 2017;494:165\u2013172. doi: 10.1016/j.bbrc.2017.10.061.", "ArticleIdList": ["10.1016/j.bbrc.2017.10.061", "29037814"]}, {"Citation": "Han S.S., Son D.J., Yun H., Kamberos N.L., Janz S. Piperlongumine inhibits proliferation and survival of Burkitt lymphoma in vitro. Leuk. Res. 2013;37:146\u2013154. doi: 10.1016/j.leukres.2012.11.009.", "ArticleIdList": ["10.1016/j.leukres.2012.11.009", "PMC3551475", "23237561"]}, {"Citation": "Zheng J., Son D.J., Gu S.M., Woo J.R., Ham Y.W., Lee H.P., Kim W.J., Jung J.K., Hong J.T. Piperlongumine inhibits lung tumor growth via inhibition of nuclear factor kappa B signaling pathway. Sci. Rep. 2016;6:26357. doi: 10.1038/srep26357.", "ArticleIdList": ["10.1038/srep26357", "PMC4873819", "27198178"]}, {"Citation": "Bezerra D.P., Ferreira P.M.P., Machado C.M.L., De Aquino N.C., Silveira E.R., Chammas R., Pessoa C. Antitumour efficacy of Piper tuberculatum and piplartine based on the hollow fiber assay. Planta Medica. 2015;81:15\u201319. doi: 10.1055/s-0034-1383363.", "ArticleIdList": ["10.1055/s-0034-1383363", "25519832"]}, {"Citation": "Zou P., Xia Y., Ji J., Chen W., Zhang J., Chen X., Rajamanickam V., Chen G., Wang Z., Chen L., et al. Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer. Cancer Lett. 2016;375:114\u2013126. doi: 10.1016/j.canlet.2016.02.058.", "ArticleIdList": ["10.1016/j.canlet.2016.02.058", "26963494"]}, {"Citation": "Ryu J., Kim M.J., Kim T.O., Huh T.L., Lee S.E. Piperlongumine as a potential activator of AMP-activated protein kinase in HepG2 cells. Nat. Prod. Res. 2014;28:2040\u20132043. doi: 10.1080/14786419.2014.919283.", "ArticleIdList": ["10.1080/14786419.2014.919283", "24853732"]}, {"Citation": "Hu Y., Luo X., Zhou J., Chen S., Gong M., Deng Y., Zhang H. Piperlongumine Inhibits the Progression of Osteosarcoma by Downregulating the SOCS3/JAK2/STAT3 Pathway via MiR-30d-5p. Life Sci. 2021;277:119501. doi: 10.1016/j.lfs.2021.119501.", "ArticleIdList": ["10.1016/j.lfs.2021.119501", "33862108"]}, {"Citation": "Lu X., Xu C., Xu Z., Lu C., Yang R., Zhang F., Zhang G. Piperlongumine Inhibits the Growth of Non-Small Cell Lung Cancer Cells via the MiR-34b-3p/TGFBR1 Pathway. BMC Complement. Med. Ther. 2021;21:15. doi: 10.1186/s12906-020-03123-y.", "ArticleIdList": ["10.1186/s12906-020-03123-y", "PMC7791704", "33413277"]}, {"Citation": "Rawat L., Hegde H., Hoti S.L., Nayak V. Piperlongumine Induces ROS Mediated Cell Death and Synergizes Paclitaxel in Human Intestinal Cancer Cells. Biomed. Pharmacother. 2020;128:110243. doi: 10.1016/j.biopha.2020.110243.", "ArticleIdList": ["10.1016/j.biopha.2020.110243", "32470748"]}, {"Citation": "Chen Y., Kuo C., Ting L., Lu L., Lu Y., Cheng A., Lin Y., Chen C., Tsai J., Chiou J. Piperlongumine Inhibits Cancer Stem Cell Properties and Regulates Multiple Malignant Phenotypes in Oral Cancer. Oncol. Lett. 2018;15:1789\u20131798. doi: 10.3892/ol.2017.7486.", "ArticleIdList": ["10.3892/ol.2017.7486", "PMC5774503", "29399195"]}, {"Citation": "Allaman-Pillet N., Schorderet D.F. Piperlongumine Promotes Death of Retinoblastoma Cancer Cells. Oncotarget. 2021;12:907\u2013916. doi: 10.18632/oncotarget.27947.", "ArticleIdList": ["10.18632/oncotarget.27947", "PMC8092346", "33953844"]}, {"Citation": "Delaney L.M., Farias N., Ghassemi Rad J., Fernando W., Annan H., Hoskin D.W. The Natural Alkaloid Piperlongumine Inhibits Metastatic Activity and Epithelial-to-Mesenchymal Transition of Triple-Negative Mammary Carcinoma Cells. Nutr. Cancer. 2021;73:2397\u20132410. doi: 10.1080/01635581.2020.1825755.", "ArticleIdList": ["10.1080/01635581.2020.1825755", "33019824"]}, {"Citation": "Zou Y., Zhao D., Yan C., Ji Y., Liu J., Xu J., Lai Y., Tian J., Zhang Y., Huang Z. Novel Ligustrazine-Based Analogs of Piperlongumine Potently Suppress Proliferation and Metastasis of Colorectal Cancer Cells in Vitro and in Vivo. J. Med. Chem. 2018;61:1821\u20131832. doi: 10.1021/acs.jmedchem.7b01096.", "ArticleIdList": ["10.1021/acs.jmedchem.7b01096", "29424539"]}, {"Citation": "Kumar S., Agnihotri N. Piperlongumine, a Piper Alkaloid Targets Ras/PI3K/Akt/MTOR Signaling Axis to Inhibit Tumor Cell Growth and Proliferation in DMH/DSS Induced Experimental Colon Cancer. Biomed. Pharmacother. 2019;109:1462\u20131477. doi: 10.1016/j.biopha.2018.10.182.", "ArticleIdList": ["10.1016/j.biopha.2018.10.182", "30551398"]}, {"Citation": "Bosc E., Nastri J., Lefort V., Valli M., Contiguiba F., Pioli R., Furlan M., Bolzani V.d.S., El Amri C., Reboud-Ravaux M. Piperlongumine and Some of Its Analogs Inhibit Selectively the Human Immunoproteasome over the Constitutive Proteasome. Biochem. Biophys. Res. Commun. 2018;496:961\u2013966. doi: 10.1016/j.bbrc.2018.01.100.", "ArticleIdList": ["10.1016/j.bbrc.2018.01.100", "29355526"]}, {"Citation": "Kumar S., Agnihotri N. Piperlongumine Targets NF-\u039aB and Its Downstream Signaling Pathways to Suppress Tumor Growth and Metastatic Potential in Experimental Colon Cancer. Mol. Cell. Biochem. 2021;476:1765\u20131781. doi: 10.1007/s11010-020-04044-7.", "ArticleIdList": ["10.1007/s11010-020-04044-7", "33433833"]}, {"Citation": "Liu Z., Shi Z., Lin J., Zhao S., Hao M., Xu J., Li Y., Zhao Q., Tao L., Diao A. Piperlongumine-Induced Nuclear Translocation of the FOXO3A Transcription Factor Triggers BIM-Mediated Apoptosis in Cancer Cells. Biochem. Pharmacol. 2019;163:101\u2013110. doi: 10.1016/j.bcp.2019.02.012.", "ArticleIdList": ["10.1016/j.bcp.2019.02.012", "30753811"]}, {"Citation": "Song X., Gao T., Lei Q., Zhang L., Yao Y., Xiong J. Piperlongumine Induces Apoptosis in Human Melanoma Cells Via Reactive Oxygen Species Mediated Mitochondria Disruption. Nutr. Cancer. 2018;70:502\u2013511. doi: 10.1080/01635581.2018.1445769.", "ArticleIdList": ["10.1080/01635581.2018.1445769", "29543494"]}, {"Citation": "Srinivas U.S., Tan B.W.Q., Vellayappan B.A., Jeyasekharan A.D. ROS and the DNA damage response in cancer. Redox Biol. 2019;25:101084. doi: 10.1016/j.redox.2018.101084.", "ArticleIdList": ["10.1016/j.redox.2018.101084", "PMC6859528", "30612957"]}, {"Citation": "Soltani A., Shams Abadi M.S., Raeisi M., Kouhihabibidehkordi G., Eshaghi F., Mohreh O., Rafieian-Kopaei M. Apoptosis-inducing Plant-based Phenolic Compounds are Effective on Leukemia Cell Lines. Curr. Pharm. Des. 2023;29:1092\u20131104. doi: 10.2174/1381612829666230417110032.", "ArticleIdList": ["10.2174/1381612829666230417110032", "37070446"]}, {"Citation": "Jorge J., Neves J., Alves R., Geraldes C., Gon\u00e7alves A.C., Sarmento-Ribeiro A.B. Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies. Int. J. Mol. Sci. 2023;24:9167. doi: 10.3390/ijms24119167.", "ArticleIdList": ["10.3390/ijms24119167", "PMC10252365", "37298119"]}, {"Citation": "Hayes J.D., Dinkova-Kostova A.T., Tew K.D. Oxidative Stress in Cancer. Cancer Cell. 2020;38:167\u2013197. doi: 10.1016/j.ccell.2020.06.001.", "ArticleIdList": ["10.1016/j.ccell.2020.06.001", "PMC7439808", "32649885"]}, {"Citation": "Pignanelli C., Ma D., Noel M., Ropat J., Mansour F., Curran C., Pupulin S., Larocque K., Wu J., Liang G., et al. Selective Targeting of Cancer Cells by Oxidative Vulnerabilities with Novel Curcumin Analogs. Sci. Rep. 2017;7:1105. doi: 10.1038/s41598-017-01230-4.", "ArticleIdList": ["10.1038/s41598-017-01230-4", "PMC5430918", "28439094"]}, {"Citation": "Kim T.H., Song J., Kim S.-H., Parikh A.K., Mo X., Palanichamy K., Kaur B., Yu J., Yoon S.O., Nakano I., et al. Piperlongumine Treatment Inactivates Peroxiredoxin 4, Exacerbates Endoplasmic Reticulum Stress, and Preferentially Kills High-Grade Glioma Cells. Neuro Oncol. 2014;16:1354\u20131364. doi: 10.1093/neuonc/nou088.", "ArticleIdList": ["10.1093/neuonc/nou088", "PMC4165421", "24879047"]}, {"Citation": "Cottini F., Hideshima T., Suzuki R., Tai Y.-T., Bianchini G., Richardson P.G., Anderson K.C., Tonon G. Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive Myeloma. Cancer Discov. 2015;5:972\u2013987. doi: 10.1158/2159-8290.CD-14-0943.", "ArticleIdList": ["10.1158/2159-8290.CD-14-0943", "PMC4560623", "26080835"]}, {"Citation": "Pei S., Minhajuddin M., Callahan K.P., Balys M., Ashton J.M., Neering S.J., Lagadinou E.D., Corbett C., Ye H., Liesveld J.L., et al. Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells. J. Biol. Chem. 2013;288:33542\u201333558. doi: 10.1074/jbc.M113.511170.", "ArticleIdList": ["10.1074/jbc.M113.511170", "PMC3837103", "24089526"]}, {"Citation": "Basak D., Punganuru S.R., Srivenugopal K.S. Piperlongumine Exerts Cytotoxic Effects against Cancer Cells with Mutant P53 Proteins at Least in Part by Restoring the Biological Functions of the Tumor Suppressor. Int. J. Oncol. 2016;48:1426\u20131436. doi: 10.3892/ijo.2016.3372.", "ArticleIdList": ["10.3892/ijo.2016.3372", "26848023"]}, {"Citation": "Han S.S., Han S., Kamberos N.L. Piperlongumine Inhibits the Proliferation and Survival of B-Cell Acute Lymphoblastic Leukemia Cell Lines Irrespective of Glucocorticoid Resistance. Biochem. Biophys. Res. Commun. 2014;452:669\u2013675. doi: 10.1016/j.bbrc.2014.08.131.", "ArticleIdList": ["10.1016/j.bbrc.2014.08.131", "25193702"]}, {"Citation": "Bissinger R., Malik A., Warsi J., Jilani K., Lang F. Piperlongumine-Induced Phosphatidylserine Translocation in the Erythrocyte Membrane. Toxins. 2014;6:2975\u20132988. doi: 10.3390/toxins6102975.", "ArticleIdList": ["10.3390/toxins6102975", "PMC4210880", "25317837"]}, {"Citation": "Adams D.J., Dai M., Pellegrino G., Wagner B.K., Stern A.M., Shamji A.F., Schreiber S.L. Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs. Proc. Natl. Acad. Sci. USA. 2012;109:15115\u201315120. doi: 10.1073/pnas.1212802109.", "ArticleIdList": ["10.1073/pnas.1212802109", "PMC3458345", "22949699"]}, {"Citation": "Qian J., Xu Z., Zhu P., Meng C., Liu Y., Shan W., He A., Gu Y., Ran F., Zhang Y., et al. A Derivative of Piperlongumine and Ligustrazine as a Potential Thioredoxin Reductase Inhibitor in Drug-Resistant Hepatocellular Carcinoma. J. Nat. Prod. 2021;84:3161\u20133168. doi: 10.1021/acs.jnatprod.1c00618.", "ArticleIdList": ["10.1021/acs.jnatprod.1c00618", "34806369"]}, {"Citation": "Qian J., Xu Z., Meng C., Liu J., Hsu P.-L., Li Y., Zhu W., Yang Y., Morris-Natschke S.L., Lee K.-H., et al. Design and Synthesis of Benzylidenecyclohexenones as TrxR Inhibitors Displaying High Anticancer Activity and Inducing ROS, Apoptosis, and Autophagy. Eur. J. Med. Chem. 2020;204:112610. doi: 10.1016/j.ejmech.2020.112610.", "ArticleIdList": ["10.1016/j.ejmech.2020.112610", "32736231"]}, {"Citation": "Meng C., Qian J., Xu Z., Liu J., Shan W., Zhu P., Zhu W., Miao J., Ling C.-C., Ling Y. Efficacy of Novel Methylenecyclohexenone Derivatives as TrxR Inhibitors in Suppressing the Proliferation and Metastasis of Human Cancer Cells. Bioorg. Chem. 2020;105:104360. doi: 10.1016/j.bioorg.2020.104360.", "ArticleIdList": ["10.1016/j.bioorg.2020.104360", "33074118"]}, {"Citation": "Yamaguchi Y., Kasukabe T., Kumakura S. Piperlongumine Rapidly Induces the Death of Human Pancreatic Cancer Cells Mainly through the Induction of Ferroptosis. Int. J. Oncol. 2018;52:1011\u20131022. doi: 10.3892/ijo.2018.4259.", "ArticleIdList": ["10.3892/ijo.2018.4259", "29393418"]}, {"Citation": "Wang X., Qian J., Zhu P., Hua R., Liu J., Hang J., Meng C., Shan W., Miao J., Ling Y. Novel Phenylmethylenecyclohexenone Derivatives as Potent TrxR Inhibitors Display High Antiproliferative Activity and Induce ROS, Apoptosis, and DNA Damage. ChemMedChem. 2021;16:702\u2013712. doi: 10.1002/cmdc.202000660.", "ArticleIdList": ["10.1002/cmdc.202000660", "33085980"]}, {"Citation": "Wang H., Jiang H., Corbet C., de Mey S., Law K., Gevaert T., Feron O., de Ridder M. Piperlongumine Increases Sensitivity of Colorectal Cancer Cells to Radiation: Involvement of ROS Production via Dual Inhibition of Glutathione and Thioredoxin Systems. Cancer Lett. 2019;450:42\u201352. doi: 10.1016/j.canlet.2019.02.034.", "ArticleIdList": ["10.1016/j.canlet.2019.02.034", "30790679"]}, {"Citation": "Yan W.J., Wang Q., Yuan C.H., Wang F., Ji Y., Dai F., Jin X.L., Zhou B. Designing piperlongumine-directed anticancer agents by an electrophilicity-based prooxidant strategy: A mechanistic investigation. Free Radic. Biol. Med. 2016;97:109\u2013123. doi: 10.1016/j.freeradbiomed.2016.05.021.", "ArticleIdList": ["10.1016/j.freeradbiomed.2016.05.021", "27233942"]}, {"Citation": "Huang B.K., Langford T.F., Sikes H.D. Using Sensors and Generators of H2O2 to Elucidate the Toxicity Mechanism of Piperlongumine and Phenethyl Isothiocyanate. Antioxid. Redox Signal. 2016;24:924\u2013938. doi: 10.1089/ars.2015.6482.", "ArticleIdList": ["10.1089/ars.2015.6482", "PMC4900193", "26905788"]}, {"Citation": "Chen Y., Liu J.M., Xiong X.X., Qiu X.Y., Pan F., Liu D., Lan S.J., Jin S., Yu S.B., Chen X.Q. Piperlongumine selectively kills hepatocellular carcinoma cells and preferentially inhibits their invasion via ROS-ER-MAPKs-CHOP. Oncotarget. 2015;6:6406\u20136421. doi: 10.18632/oncotarget.3444.", "ArticleIdList": ["10.18632/oncotarget.3444", "PMC4467445", "25788268"]}, {"Citation": "Han J.G., Gupta S.C., Prasad S., Aggarwal B.B. Piperlongumine chemosensitizes tumor cells through interaction with cysteine 179 of I\u03baB\u03b1 kinase, leading to suppression of NF-\u03baB-regulated gene products. Mol. Cancer Ther. 2014;13:2422\u20132435. doi: 10.1158/1535-7163.MCT-14-0171.", "ArticleIdList": ["10.1158/1535-7163.MCT-14-0171", "25082961"]}, {"Citation": "Roh J.L., Kim E.H., Park J.Y., Kim J.W., Kwon M., Lee B.H. Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer. Oncotarget. 2014;5:9227\u20139238. doi: 10.18632/oncotarget.2402.", "ArticleIdList": ["10.18632/oncotarget.2402", "PMC4253430", "25193861"]}, {"Citation": "Fofaria N.M., Srivastava S.K. STAT3 induces anoikis resistance, promotes cell invasion and metastatic potential in pancreatic cancer cells. Carcinogenesis. 2015;36:142\u2013150. doi: 10.1093/carcin/bgu233.", "ArticleIdList": ["10.1093/carcin/bgu233", "PMC4291051", "25411359"]}, {"Citation": "Faria C.C., Agnihotri S., Mack S.C., Golbourn B.J., Diaz R.J., Olsen S., Bryant M., Bebenek M., Wang X., Bertrand K.C., et al. Identification of alsterpaullone as a novel small molecule inhibitor to target group 3 medulloblastoma. Oncotarget. 2015;6:21718\u201321729. doi: 10.18632/oncotarget.4304.", "ArticleIdList": ["10.18632/oncotarget.4304", "PMC4673298", "26061748"]}, {"Citation": "Wang H., Wang Y., Gao H., Wang B., Dou L., Li Y. Piperlongumine Induces Apoptosis and Autophagy in Leukemic Cells through Targeting the PI3K/Akt/MTOR and P38 Signaling Pathways. Oncol. Lett. 2018;15:1423\u20131428. doi: 10.3892/ol.2017.7498.", "ArticleIdList": ["10.3892/ol.2017.7498", "PMC5774427", "29434833"]}, {"Citation": "Zhang Y., Ma H., Wu Y., Wu Z., Yao Z., Zhang W., Zhuang C., Miao Z. Novel non-trimethoxylphenyl piperlongumine derivatives selectively kill cancer cells. Bioorg. Med. Chem. Lett. 2017;27:2308\u20132312. doi: 10.1016/j.bmcl.2017.04.035.", "ArticleIdList": ["10.1016/j.bmcl.2017.04.035", "28434764"]}, {"Citation": "Okamoto S., Narita T., Sasanuma H., Takeda S., Masunaga S., Bessho T., Tano K. Impact of DNA repair pathways on the cytotoxicity of piperlongumine in chicken DT40 cell-lines. Genes Cancer. 2014;5:285\u2013292. doi: 10.18632/genesandcancer.26.", "ArticleIdList": ["10.18632/genesandcancer.26", "PMC4162141", "25221646"]}, {"Citation": "Lee H.N., Jin H.O., Park J.A., Kim J.H., Kim J.Y., Kim B., Kim W., Hong S.E., Lee Y.H., Chang Y.H., et al. Heme oxygenase-1 determines the differential response of breast cancer and normal cells to piperlongumine. Mol. Cells. 2015;38:327\u2013335. doi: 10.14348/molcells.2015.2235.", "ArticleIdList": ["10.14348/molcells.2015.2235", "PMC4400307", "25813625"]}, {"Citation": "Wu Y., Min X., Zhuang C., Li J., Yu Z., Dong G., Yao J., Wang S., Liu Y., Wu S., et al. Design, synthesis and biological activity of piperlongumine derivatives as selective anticancer agents. Eur. J. Med. Chem. 2014;82:545\u2013551. doi: 10.1016/j.ejmech.2014.05.070.", "ArticleIdList": ["10.1016/j.ejmech.2014.05.070", "24937186"]}, {"Citation": "Randhawa H., Kibble K., Zeng H., Moyer M.P., Reindl K.M. Activation of ERK Signaling and Induction of Colon Cancer Cell Death by Piperlongumine. Toxicol. Vitr. 2013;27:1626\u20131633. doi: 10.1016/j.tiv.2013.04.006.", "ArticleIdList": ["10.1016/j.tiv.2013.04.006", "PMC3749270", "23603476"]}, {"Citation": "Yao Y., Sun Y., Shi M., Xia D., Zhao K., Zeng L., Yao R., Zhang Y., Li Z., Niu M., et al. Piperlongumine Induces Apoptosis and Reduces Bortezomib Resistance by Inhibiting STAT3 in Multiple Myeloma Cells. Oncotarget. 2016;7:73497\u201373508. doi: 10.18632/oncotarget.11988.", "ArticleIdList": ["10.18632/oncotarget.11988", "PMC5341994", "27634873"]}, {"Citation": "Machado F.S., Munari F.M., Scariot F.J., Echeverrigaray S., Aguzzoli C., Pich C.T., Kato M.J., Yamaguchi L., Moura S., Henriques J.A.P., et al. Piperlongumine Induces Apoptosis in Colorectal Cancer HCT 116 Cells Independent of Bax, p21 and p53 Status. Anticancer. Res. 2018;38:6231\u20136236. doi: 10.21873/anticanres.12978.", "ArticleIdList": ["10.21873/anticanres.12978", "30396942"]}, {"Citation": "Zhang D.F., Yang Z.C., Chen J.Q., Jin X.X., Qiu Y.D., Chen X.J., Shi H.Y., Liu Z.G., Wang M.S., Liang G., et al. Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage. BMC Complement. Med. Ther. 2021;21:195. doi: 10.1186/s12906-021-03369-0.", "ArticleIdList": ["10.1186/s12906-021-03369-0", "PMC8261967", "34229670"]}, {"Citation": "Mohammad J., Singh R.R., Riggle C., Haugrud B., Abdalla M.Y., Reindl K.M. JNK Inhibition Blocks Piperlongumine-Induced Cell Death and Transcriptional Activation of Heme Oxygenase-1 in Pancreatic Cancer Cells. Apoptosis. 2019;24:730\u2013744. doi: 10.1007/s10495-019-01553-9.", "ArticleIdList": ["10.1007/s10495-019-01553-9", "PMC6713602", "31243599"]}, {"Citation": "Nan X.-W., Gong L.-H., Chen X., Zhou H.-H., Ye P.-P., Yang Y., Xing Z.-H., Wei M.-N., Li Y., Wang S.-T., et al. Survivin Promotes Piperlongumine Resistance in Ovarian Cancer. Front. Oncol. 2019;9:1345. doi: 10.3389/fonc.2019.01345.", "ArticleIdList": ["10.3389/fonc.2019.01345", "PMC6895030", "31850227"]}, {"Citation": "Chen W., Lian W., Yuan Y., Li M. The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress. Cell Death Dis. 2019;10:600. doi: 10.1038/s41419-019-1824-6.", "ArticleIdList": ["10.1038/s41419-019-1824-6", "PMC6687721", "31395855"]}, {"Citation": "Zhou L., Li M., Yu X., Gao F., Li W. Repression of Hexokinases II-Mediated Glycolysis Contributes to Piperlongumine-Induced Tumor Suppression in Non-Small Cell Lung Cancer Cells. Int. J. Biol. Sci. 2019;15:826\u2013837. doi: 10.7150/ijbs.31749.", "ArticleIdList": ["10.7150/ijbs.31749", "PMC6429016", "30906213"]}, {"Citation": "Gao F., Zhou L., Li M., Liu W., Yang S., Li W. Inhibition of ERKs/Akt-Mediated c-Fos Expression Is Required for Piperlongumine-Induced Cyclin D1 Downregulation and Tumor Suppression in Colorectal Cancer Cells. Onco Targets Ther. 2020;13:5591\u20135603. doi: 10.2147/OTT.S251295.", "ArticleIdList": ["10.2147/OTT.S251295", "PMC7304781", "32606774"]}, {"Citation": "Afolabi L.O., Bi J., Chen L., Wan X. A Natural Product, Piperlongumine (PL), Increases Tumor Cells Sensitivity to NK Cell Killing. Int. Immunopharmacol. 2021;96:107658. doi: 10.1016/j.intimp.2021.107658.", "ArticleIdList": ["10.1016/j.intimp.2021.107658", "33887610"]}, {"Citation": "Duan C., Zhang B., Deng C., Cao Y., Zhou F., Wu L., Chen M., Shen S., Xu G., Zhang S., et al. Piperlongumine induces gastric cancer cell apoptosis and G2/M cell cycle arrest both in vitro and in vivo. Tumor Biol. 2016;37:10793\u201310804. doi: 10.1007/s13277-016-4792-9.", "ArticleIdList": ["10.1007/s13277-016-4792-9", "26874726"]}, {"Citation": "Liu J.M., Pan F., Li L., Liu Q.R., Chen Y., Xiong X.X., Cheng K., Yu S.B., Shi Z., Yu A.C., et al. Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation. Biochem. Biophys. Res. Commun. 2013;437:87\u201393. doi: 10.1016/j.bbrc.2013.06.042.", "ArticleIdList": ["10.1016/j.bbrc.2013.06.042", "23796709"]}, {"Citation": "Henrique T., Zanon C.d.F., Girol A.P., Stefanini A.C.B., Contessoto N.S.d.A., da Silveira N.J.F., Bezerra D.P., Silveira E.R., Barbosa-Filho J.M., Corn\u00e9lio M.L., et al. Biological and physical approaches on the role of piplartine (piperlongumine) in cancer. Sci. Rep. 2020;10:22283. doi: 10.1038/s41598-020-78220-6.", "ArticleIdList": ["10.1038/s41598-020-78220-6", "PMC7746756", "33335138"]}, {"Citation": "Yuan H., Houck K.L., Tian Y., Bharadwaj U., Hull K., Zhou Z., Zhou M., Wu X., Tweardy D.J., Romo D., et al. Piperlongumine Blocks JAK2-STAT3 to Inhibit Collagen-Induced Platelet Reactivity Independent of Reactive Oxygen Species. PLoS ONE. 2015;10:e0143964. doi: 10.1371/journal.pone.0143964.", "ArticleIdList": ["10.1371/journal.pone.0143964", "PMC4672935", "26645674"]}, {"Citation": "Maund S.L., Nolley R., Peehl D.M. Optimization and Comprehensive Characterization of a Faithful Tissue Culture Model of the Benign and Malignant Human Prostate. Lab. Investig. 2014;94:208\u2013221. doi: 10.1038/labinvest.2013.141.", "ArticleIdList": ["10.1038/labinvest.2013.141", "PMC3946793", "24296879"]}, {"Citation": "Farrand L., Kim J.Y., Im-Aram A., Suh J.-Y., Lee H.J., Tsang B.K. An Improved Quantitative Approach for the Assessment of Mitochondrial Fragmentation in Chemoresistant Ovarian Cancer Cells. PLoS ONE. 2013;8:e74008. doi: 10.1371/journal.pone.0074008.", "ArticleIdList": ["10.1371/journal.pone.0074008", "PMC3767598", "24040144"]}, {"Citation": "Cheng X., Tian P., Zheng W., Yan X. Piplartine Attenuates the Proliferation of Hepatocellular Carcinoma Cells via Regulating Hsa_circ_100338 Expression. Cancer Med. 2020;9:4265\u20134273. doi: 10.1002/cam4.3043.", "ArticleIdList": ["10.1002/cam4.3043", "PMC7300402", "32281302"]}, {"Citation": "Jin H.O., Lee Y.H., Park J.A., Lee H.N., Kim J.H., Kim J.Y., Kim B., Hong S.E., Kim H.A., Kim E.K., et al. Piperlongumine Induces Cell Death through ROS-Mediated CHOP Activation and Potentiates TRAIL-Induced Cell Death in Breast Cancer Cells. J. Cancer Res. Clin. Oncol. 2014;140:2039\u20132046. doi: 10.1007/s00432-014-1777-1.", "ArticleIdList": ["10.1007/s00432-014-1777-1", "25023940"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "7", "Day": "21"}, {"Year": "2023", "Month": "8", "Day": "9"}, {"Year": "2023", "Month": "8", "Day": "23"}, {"Year": "2023", "Month": "9", "Day": "28", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "9", "Day": "28", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "9", "Day": "28", "Hour": "1", "Minute": "37"}, {"Year": "2023", "Month": "9", "Day": "4"}], "PublicationStatus": "epublish", "ArticleIdList": ["37765054", "PMC10535094", "10.3390/ph16091246", "ph16091246"]}}], "PubmedBookArticle": []}